|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 45/00 | |
| A61K 31/395 | |||
| A61P 31/12 |
| (11) | Number of the document | 3478322 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17736709.1 |
| Date of filing the European patent application | 2017-06-26 | |
| (97) | Date of publication of the European application | 2019-05-08 |
| (45) | Date of publication and mention of the grant of the patent | 2020-12-30 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/GB2017/051865 |
| Date | 2017-06-26 |
| (87) | Number | WO 2018/007788 |
| Date | 2018-01-11 |
| (30) | Number | Date | Country code |
| 201611712 | 2016-07-02 | GB |
| (72) |
WHITTAKER, Paul, Andrew, GB
TORBETT, Neil, Edward, GB
|
| (73) |
Orph Pharma IP Company Limited ,
Queen Mary Bioenterprises Innovation Centre
42 New Road, London
E1 2AX,
GB
|
| (54) | METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA |
| METHODS AND COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SEVERE INFLUENZA |